Publications:
Meningococcal Conjugate
Other Relevant MMWR Publications
-
December 7, 2007, Vol 56, #48
Notice to Readers: Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal Disease -
August 10, 2007, Vol 56, #31
Notice to Readers: Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine -
November 3, 2006, Vol 55, #43
Notice to Readers: Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11-12 Years -
October 20, 2006, Vol 55, #41
Update: Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine -- United States, June 2005-September 2006 -
September 22, 2006, Vol 55, #37
Inadvertent Misadministration of Meningococcal Conjugate Vaccine -- United States, June-August 2005 -
May 26, 2006, Vol 55, #20
Notice to Readers: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11-12 Years -
April 7 , 2006, Vol 55, #13
Update: Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine -- United States, October 2005-February 2006 -
October 14 , 2005, Vol 54, #40
Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine -- United States, June-July 2005 -
Feb 14 , 1997, Vol 46, #RR-5
Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Return to ACIP-related MMWR page
Content last reviewed on May 19, 2007
Content Source: National Center for Immunization and Respiratory Diseases